OBIO

ORCHESTRA BIOMED HLDGS INC

OBIO·68572M106·US·Common Stock·Healthcare - Biotechnology-Activist

OBIO (ORCHESTRA BIOMED HLDGS INC) is held by 39 institutional investors as of Q1 2026. Largest holders: RTW INVESTMENTS, LP ($35.3M), VANGUARD CAPITAL MANAGEMENT LLC ($9.4M), Alyeska Investment Group, L.P. ($4.3M). Net institutional sentiment: Mixed.

39
Holders
Avg rating(6 Elite)
$65.9M
Total Value
53% (51)
Fund Consensus
25 buying - 22 selling
OBIOSmart Money Verdict
View all
Held by 39 funds
6 elite
Who's Trading
InsiderAJAryeh JasonBuy $2KMay 18, 2026
InsiderHPHochman David PBuy $19KMay 15, 2026
InsiderAJAryeh JasonBuy $35KMay 15, 2026
InsiderFSFain Eric SBuy $83KMay 14, 2026
ActivistRTW Investments, LPRTW Investments, LP19.2%Apr 29, 2026
InsiderRLRTW INVESTMENTS, LPSell $132.16Apr 27, 2026
InsiderHPHochman David PBuy $43KMar 13, 2026
ActivistMPMedtronic plc17.8%Feb 27, 2026
ActivistTATasso Partners, LLC5.0%Nov 19, 2025
InsiderHPHochman David PBuy $20KNov 14, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Unchanged
8.3M$35.3M0.4%-65.58%
0
New
2.2M$9.4M0.0%-8.49%
38
Unchanged
1M$4.3M0.0%+62.20%
0
Increased
702,543(+188.6%)$3M0.0%+4.66%
43
Increased
635,714(+0.8%)$2.7M0.0%-6.14%
18
Increased
485,492(+2.6%)$2.1M0.0%-44.69%
27
Increased
265,499(+0.7%)$1.1M0.0%-44.22%
25
New
235,214$999,6600.0%-8.49%
35
Increased
188,484(+9.8%)$801,0590.0%-4.08%
27
Increased
169,410(+6.5%)$719,9930.0%-38.18%
18
Increased
155,242(+15.8%)$659,7790.0%-2.10%
28
Increased
118,274(+6.7%)$502,6650.0%-44.18%
26
Increased
108,953(+2.1%)$463,0500.0%+6.55%
24
Decreased
97,521(-37.1%)$414,4640.0%+12.23%
0
Decreased
87,888(-45.7%)$373,5240.0%-3.62%
0
Increased
79,185(+162.4%)$336,5360.0%-1.13%
38
Increased
71,134(+43.9%)$302,3200.0%-5.16%
32
Decreased
70,900(-53.1%)$301,3250.0%+53.31%
0
Decreased
60,107(-30.6%)$255,4550.0%-3.62%
0
Decreased
59,342(-37.2%)$252,2040.0%-3.62%
0

Showing 1-20 of 51

1 / 3

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used